Multi-Periscopic Prism (MPP) glasses for Homonymous Hemianopia
This trial will compare two types of high-power prism glasses to help patients with half-blindness caused by damage to the same side of both eyes.
- Homonymous Hemianopia
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there vacancies available for patients to join this clinical experiment?
"Data hosted on clinicaltrials.gov explicates that this trial is not presently recruiting patients, despite having been initially posted January 1st 2023 and last updated August 22nd 2022. However, 11 other medical studies are currently enrolling participants at the moment."
What qualifications must a participant fulfill to be eligible for this clinical trial?
"This clinical trial requires 65 people with hemianopsia to participate, with ages ranging from 7-80 years. Crucially, these individuals must possess minimum visual acuity of 20/50 in each eye (corrective lenses if needed), and be able walk independently or with the aid of a cane or walking frame."
Are elderly individuals eligible to be enrolled in this clinical trial?
"This clinical trial is limited to participants aged 7-80. Concurrently, there are 5 trials for minors and 10 studies that focus on patients above the age of 65."